Ranier’s Compounding Laboratory Draws Form 483, Safety Alert Over Sterility Issues

Drug Industry Daily
In a follow-up inspection to a March 2017 warning letter, the FDA issued a Form 483 to Ranier’s Compounding Laboratory, accompanied by a public safety alert warning healthcare professionals and patients not to use the facility’s products purporting to be sterile.

To View This Article:


Subscribe To Drug Industry Daily